Molecular chaperones biochemistry and role in neurodegenerative diseases.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Jun 2019
Historique:
received: 21 11 2018
revised: 25 02 2019
accepted: 25 02 2019
pubmed: 12 3 2019
medline: 10 9 2019
entrez: 12 3 2019
Statut: ppublish

Résumé

Many neurodegenerative diseases including Parkinson's disease, Alzheimer's disease, Prion's disease, polyQ and Huntington's disease share abnormal folding of potentially cytotoxic protein species associated with degeneration and death of specific neuronal populations. In order to maintain cellular protein homeostasis, neurons have developed an intrinsic protein quality control system as a strategy to counteract protein aggregation and their toxicity. Heat shock proteins are an essential component for regulating protein quality control and contribute potentially in the process of protein folding, prevent protein aggregation and in disaggregation in several neurodegenerative diseases. Therefore, molecular chaperones are considered an exciting therapeutic target. In this book chapter, we will focus on the potential importance of different heat shock proteins in neurodegenerative diseases and understand their mechanisms to protect neurons form aggregates and their toxicity.

Identifiants

pubmed: 30853582
pii: S0141-8130(18)36375-X
doi: 10.1016/j.ijbiomac.2019.02.148
pii:
doi:

Substances chimiques

Molecular Chaperones 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

396-411

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Ali Chaari (A)

Premedical Department Division, Weill Cornell Medicine, Qatar Foundation, Education City, P.O. Box 24144, Doha, Qatar. Electronic address: alc2033@qatar-med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH